Provision of Bordetella-Free Baboons for Pertussis Infection and Vaccination Studies
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
This opportunity closed July 10, 2026. 5 similar opportunities are open right now.
Similar opportunities open now
- Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreakSame funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center (IMPAc-TB)Same funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFCloses in 18 days
- BARDA DRIVe EZ-BAA-22-100-SOL-00003Same funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFCloses Oct 2027
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)Same funderOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFCloses Sep 2028
- 6550--NOITSS - Zeus Scientific Borrelia MTTT Lyme Elisa TestingOpenVETERANS AFFAIRS, DEPARTMENT OFNo deadline listed
About this archived opportunity
6/29/2026; See attached amendment 1 to the combined synopsis/solicitation. Pertussis is an acute, highly contagious, potentially life-threatening respiratory disease, caused by the Gram-negative bacterium Bordetella pertussis. The underlying factors leading to the failure of public health measures to control pertussis disease using currently licensed vaccines are poorly understood. A more complete understanding of this disease and of the mechanisms of vaccine-mediated protection is a critical public health need. The baboon model of pertussis, developed in the laboratories of the Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), is the only animal model of pertussis that recapitulates the disease as observed in human patients. Refinement of the baboon model to include establishment of infection by means of natural transmission will enable a more refine evaluation of the differences between the licensed acellular pertussis vaccines that fail to prevent infection and the whole cell vaccines that reduce infection. The performance of this study requires the purchase and delivery of twenty, Bordetella-free baboons.
Historical details
- Status
- Closed
- Deadline
- July 10, 2026
- First captured
- June 30, 2026
- Publisher reference
- a3a0d837a54747d39a3893ac8c767908
Eligibility: No Set aside used. NONE
Free. One email, sent if this program reopens or a close match to it opens. We watch for 12 months, then stop. No list.
Related opportunities
- Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreakSame funderHEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center (IMPAc-TB)Same funderHEALTH AND HUMAN SERVICES, DEPARTMENT OFCloses in 18 days
- BARDA DRIVe EZ-BAA-22-100-SOL-00003Same funderHEALTH AND HUMAN SERVICES, DEPARTMENT OFCloses Oct 2027
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)Same funderHEALTH AND HUMAN SERVICES, DEPARTMENT OFCloses Sep 2028
- 6550--NOITSS - Zeus Scientific Borrelia MTTT Lyme Elisa TestingVETERANS AFFAIRS, DEPARTMENT OF
- BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EBDEPT OF DEFENSECloses Jun 2027